MSB 2.51% 97.0¢ mesoblast limited

Ann: FDA Advisory Committee Sets Review Date for Remestemcel-L, page-547

  1. 30,350 Posts.
    lightbulb Created with Sketch. 1845
    The point is that MSB itself has guided the FDA. SI is an advisor to the FDA.

    Calm down people and research properly!
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.